{"title":"来自巴基斯坦三级医院的新冠肺炎感染中嗜酸性粒细胞减少和中性粒细胞/淋巴细胞比率的前瞻性研究","authors":"Gul Anum","doi":"10.22442/jlumhs.2023.01008","DOIUrl":null,"url":null,"abstract":"OBJECTIVE: To assess eosinopenia and neutrophil to lymphocyte ratio in patients admitted with COVID-19 infection and correlate with pneumonia severity. METHODOLOGY: This prospective observational study was conducted at Covid HDU of Dr.Ruth KM Pfau Civil Hospital, Karachi, from October - December 2021. Data was collected using convenience sampling. The inclusion criteria were patients between 18-70 years with symptoms suggestive of COVID-19 and positive RT-PCR. Patients with negative RT-PCR with alternate diagnosis, history of using a corticosteroid, pancreatic or esophageal malignancy, and recent burn were excluded. Data analysis was done using SPSS version 23. RESULTS: Out of 141 patients, 66(46%) were classified as non-severe covid and 75(53.9%) as severe covid pneumonia. A significant association between eosinopenia and COVID severity was observed. The NLR was significantly increased in severe COVID patients compared to non- severe patients. Similarly, eosinophil was decreased considerably in severe covid compared to non-severe patients (p-value<0.05). The area under the eosinopenia ROC curve is 0.71 and 0.69 on days 7 and 3, respectively. Thus, eosinopenia on day 7 was fair in predicting severe COVID- 19 pneumonia compared with increased NLR, which was poor in predicting severe COVID-19. Using the area under the ROC curve, an eosinophil count cutoff of < 100 cells/mm3 produced a sensitivity of 75% for severe COVID-19 pneumonia. CONCLUSION: Eosinopenia and elevated NLR were found with increased frequency in patients with severe COVID-19 pneumonia; however, persistent eosinopenia was a better marker than NLR in predicting COVID-19 infection severity. KEYWORDS: Eosinopenia, Neutrophil to lymphocyte ratio, Covid-19, Pneumonia","PeriodicalId":43685,"journal":{"name":"Journal of the Liaquat University of Medical and Health Sciences","volume":null,"pages":null},"PeriodicalIF":0.1000,"publicationDate":"2023-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Eosinopenia and Neutrophil to Lymphocyte Ratio in COVID-19 Infection, a Prospective Study from Tertiary Care Hospital in Pakistan\",\"authors\":\"Gul Anum\",\"doi\":\"10.22442/jlumhs.2023.01008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"OBJECTIVE: To assess eosinopenia and neutrophil to lymphocyte ratio in patients admitted with COVID-19 infection and correlate with pneumonia severity. METHODOLOGY: This prospective observational study was conducted at Covid HDU of Dr.Ruth KM Pfau Civil Hospital, Karachi, from October - December 2021. Data was collected using convenience sampling. The inclusion criteria were patients between 18-70 years with symptoms suggestive of COVID-19 and positive RT-PCR. Patients with negative RT-PCR with alternate diagnosis, history of using a corticosteroid, pancreatic or esophageal malignancy, and recent burn were excluded. Data analysis was done using SPSS version 23. RESULTS: Out of 141 patients, 66(46%) were classified as non-severe covid and 75(53.9%) as severe covid pneumonia. A significant association between eosinopenia and COVID severity was observed. The NLR was significantly increased in severe COVID patients compared to non- severe patients. Similarly, eosinophil was decreased considerably in severe covid compared to non-severe patients (p-value<0.05). The area under the eosinopenia ROC curve is 0.71 and 0.69 on days 7 and 3, respectively. Thus, eosinopenia on day 7 was fair in predicting severe COVID- 19 pneumonia compared with increased NLR, which was poor in predicting severe COVID-19. Using the area under the ROC curve, an eosinophil count cutoff of < 100 cells/mm3 produced a sensitivity of 75% for severe COVID-19 pneumonia. CONCLUSION: Eosinopenia and elevated NLR were found with increased frequency in patients with severe COVID-19 pneumonia; however, persistent eosinopenia was a better marker than NLR in predicting COVID-19 infection severity. KEYWORDS: Eosinopenia, Neutrophil to lymphocyte ratio, Covid-19, Pneumonia\",\"PeriodicalId\":43685,\"journal\":{\"name\":\"Journal of the Liaquat University of Medical and Health Sciences\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2023-11-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the Liaquat University of Medical and Health Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22442/jlumhs.2023.01008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Liaquat University of Medical and Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22442/jlumhs.2023.01008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
摘要
目的:探讨新冠肺炎(COVID-19)感染患者红细胞减少和中性粒细胞/淋巴细胞比值与肺炎严重程度的相关性。方法:这项前瞻性观察性研究于2021年10月至12月在卡拉奇ruth KM Pfau民用医院的新冠HDU进行。采用方便抽样法收集数据。纳入标准为年龄在18-70岁之间,伴有COVID-19症状且RT-PCR阳性的患者。排除有其他诊断、使用皮质类固醇史、胰腺或食管恶性肿瘤以及近期烧伤的RT-PCR阴性患者。数据分析使用SPSS version 23。结果:141例患者中,66例(46%)为非重症肺炎,75例(53.9%)为重症肺炎。观察到红细胞减少与COVID严重程度之间存在显著关联。重症患者的NLR明显高于非重症患者。同样,与非重症患者相比,重症患者的嗜酸性粒细胞明显减少(p值<0.05)。第7天和第3天,红细胞减少ROC曲线下面积分别为0.71和0.69。因此,与NLR升高相比,第7天的红细胞减少在预测严重的COVID-19肺炎方面是公平的,而NLR升高在预测严重的COVID-19肺炎方面较差。利用ROC曲线下的面积,嗜酸性粒细胞计数的临界值<100个细胞/mm3对严重COVID-19肺炎的敏感性为75%。结论:COVID-19重症肺炎患者红细胞减少、NLR升高发生率增高;然而,在预测COVID-19感染严重程度方面,持续红细胞减少比NLR更好。关键词:嗜酸性粒细胞减少,中性粒细胞与淋巴细胞比值,Covid-19,肺炎
Eosinopenia and Neutrophil to Lymphocyte Ratio in COVID-19 Infection, a Prospective Study from Tertiary Care Hospital in Pakistan
OBJECTIVE: To assess eosinopenia and neutrophil to lymphocyte ratio in patients admitted with COVID-19 infection and correlate with pneumonia severity. METHODOLOGY: This prospective observational study was conducted at Covid HDU of Dr.Ruth KM Pfau Civil Hospital, Karachi, from October - December 2021. Data was collected using convenience sampling. The inclusion criteria were patients between 18-70 years with symptoms suggestive of COVID-19 and positive RT-PCR. Patients with negative RT-PCR with alternate diagnosis, history of using a corticosteroid, pancreatic or esophageal malignancy, and recent burn were excluded. Data analysis was done using SPSS version 23. RESULTS: Out of 141 patients, 66(46%) were classified as non-severe covid and 75(53.9%) as severe covid pneumonia. A significant association between eosinopenia and COVID severity was observed. The NLR was significantly increased in severe COVID patients compared to non- severe patients. Similarly, eosinophil was decreased considerably in severe covid compared to non-severe patients (p-value<0.05). The area under the eosinopenia ROC curve is 0.71 and 0.69 on days 7 and 3, respectively. Thus, eosinopenia on day 7 was fair in predicting severe COVID- 19 pneumonia compared with increased NLR, which was poor in predicting severe COVID-19. Using the area under the ROC curve, an eosinophil count cutoff of < 100 cells/mm3 produced a sensitivity of 75% for severe COVID-19 pneumonia. CONCLUSION: Eosinopenia and elevated NLR were found with increased frequency in patients with severe COVID-19 pneumonia; however, persistent eosinopenia was a better marker than NLR in predicting COVID-19 infection severity. KEYWORDS: Eosinopenia, Neutrophil to lymphocyte ratio, Covid-19, Pneumonia
期刊介绍:
Journal of Liaquat University of Medical and Health Sciences (JLUMHS) Jamshoro, Pakistan publishes original manuscripts, case reports and reviews on topics related to medical and health sciences. JLUMHS is a peer reviewed journal and is published quarterly (4 issues per year) since July 2002. It agrees to accept manuscripts prepared in accordance with the “Uniform Requirements for submission of manuscripts for biomedical journals adopted by International Committee of Medical Journal Editors (ICMJE), updated October 2001 (Refer JLUMHS July – December 2002 issue).